Fundraising Fox

Doug Williams

Investor

Biotech Executive & Founding Pillar at Pillar VC

United States

About

Doug Williams has held senior leadership roles across the biotechnology industry, including Executive Vice President of Research and Development at Biogen, CEO of ZymoGenetics (which he led through its acquisition by Bristol Myers Squibb), and Chief Scientific Officer and EVP of R&D at Seattle Genetics. He previously served as Senior Vice President and Washington Site Leader at Amgen and as EVP, Chief Technology Officer, and board member at Immunex. He holds a Ph.D. from the State University of New York at Buffalo, Roswell Park Division, and completed a postdoctoral fellowship at Indiana University School of Medicine.

Invests in

Biotech

Experience

  1. Codiak BioSciencesCEO
  2. Codiak BioSciencesPresident & CEOcurrent2015 β€” presentCambridge, MA
  3. BiogenExecutive Vice President Research & Development2011 β€” 2015Cambridge, MA
  4. ZymoGeneticsCEO2009 β€” 2010Seattle, WA
  5. ZymoGeneticsPresident & Chief Scientific Officer2007 β€” 2008Seattle, WA
  6. ZymoGeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2004 β€” 2007Seattle, WA
  7. Seattle GeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2003 β€” 2004Bothell, WA
  8. Genesis Research & Development Corp, LtdHead of Health and Strategic Development2002 β€” 2003Auckland, Auckland, New Zealand
  9. Amgen WashingtonSenior Vice President2002Seattle, WA
  10. Immunex CorporationExecutive Vice President & Chief Technology Officer1999 β€” 2002Seattle, WA
  11. Immunex CorporationSenior Vice President, Discovery Research1994 β€” 1999Seattle, WA
  12. Immunex Research & Development Corp.Vice President1992 β€” 1994Seattle, WA
  13. Immunex Research & Development CorpDirector1989 β€” 1991Seattle, WA
  14. Immunex Research & Development CorpStaff Scientist1988Seattle, WA

Investments

Board seats

AC Immune SAStablix

Per the firm's website.

Colleagues at Pillar VC

Frequently asked questions

Who is Doug Williams?
Doug Williams has held senior leadership roles across the biotechnology industry, including Executive Vice President of Research and Development at Biogen, CEO of ZymoGenetics (which he led through its acquisition by Bristol Myers Squibb), and Chief Scientific Officer and EVP of R&D at Seattle Genetics. He previously served as Senior Vice President and Washington Site Leader at Amgen and as EVP, Chief Technology Officer, and board member at Immunex. He holds a Ph.D. from the State University of New York at Buffalo, Roswell Park Division, and completed a postdoctoral fellowship at Indiana University School of Medicine.
Where does Doug Williams work?
Doug Williams is Biotech Executive & Founding Pillar at Pillar VC.
What does Doug Williams invest in?
Doug Williams invests in Biotech.
What boards does Doug Williams sit on?
Doug Williams holds tracked board seats at AC Immune SA, Stablix.
Where did Doug Williams go to school?
Doug Williams studied at Indiana University School of Medicine (Postdoctoral Fellow, Division of Hematology/Oncology); University at Buffalo Pharmacy and Pharmaceutical Sciences (Ph.D.); Greenfield Community College (Associates Degree, Liberal Arts and Sciences/Liberal Studies).

Founder mafias

Same school

Shared employers